157 related articles for article (PubMed ID: 1550824)
21. Structural basis of DNA recognition by anticancer antibiotics, chromomycin A(3), and mithramycin: roles of minor groove width and ligand flexibility.
Chakrabarti S; Bhattacharyya D; Dasgupta D
Biopolymers; 2000-2001; 56(2):85-95. PubMed ID: 11592055
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of complexation of metal-mediated DNA-binding drugs to oligonucleotides via electrospray ionization mass spectrometry.
Reyzer ML; Brodbelt JS; Kerwin SM; Kumar D
Nucleic Acids Res; 2001 Nov; 29(21):E103-3. PubMed ID: 11691940
[TBL] [Abstract][Full Text] [Related]
23. New DNA binding ligands as a model of chromomycin A3.
Imoto S; Haruta Y; Watanabe K; Sasaki S
Bioorg Med Chem Lett; 2004 Oct; 14(19):4855-9. PubMed ID: 15341939
[TBL] [Abstract][Full Text] [Related]
24. Interaction of antitumor drug, mithramycin, with chromatin.
Mir MA; Dasgupta D
Biochem Biophys Res Commun; 2001 Jan; 280(1):68-74. PubMed ID: 11162479
[TBL] [Abstract][Full Text] [Related]
25. NMR studies of the interaction of chromomycin A3 with small DNA duplexes. Binding to GC-containing sequences.
Banville DL; Keniry MA; Kam M; Shafer RH
Biochemistry; 1990 Jul; 29(27):6521-34. PubMed ID: 2207094
[TBL] [Abstract][Full Text] [Related]
26. Interaction of mithramycin with chromatin.
Mir MA; Dasgupta D
Indian J Biochem Biophys; 2001; 38(1-2):71-4. PubMed ID: 11563335
[TBL] [Abstract][Full Text] [Related]
27. Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3.
Mir MA; Majee S; Das S; Dasgupta D
Bioorg Med Chem; 2003 Jul; 11(13):2791-801. PubMed ID: 12788353
[TBL] [Abstract][Full Text] [Related]
28. Mode of action of antitumour antibiotics. spectrophotometric studies on the interaction of chromomycin A3 with DNA and chromatin of normal and neoplastic tissue.
Nayak R; Sirsi M; Podder K
Biochim Biophys Acta; 1975 Jan; 378(2):195-204. PubMed ID: 1125225
[TBL] [Abstract][Full Text] [Related]
29. Chromomycin dimer-DNA oligomer complexes. Sequence selectivity and divalent cation specificity.
Gao XL; Patel DJ
Biochemistry; 1990 Dec; 29(49):10940-56. PubMed ID: 2176890
[TBL] [Abstract][Full Text] [Related]
30. The crucial role of divalent metal ions in the DNA-acting efficacy and inhibition of the transcription of dimeric chromomycin A3.
Hsu CW; Chuang SM; Wu WL; Hou MH
PLoS One; 2012; 7(9):e43792. PubMed ID: 22984445
[TBL] [Abstract][Full Text] [Related]
31. The impact of spermine competition on the efficacy of DNA-binding Fe(II), Co(II), and Cu(II) complexes of dimeric chromomycin A(3).
Lu WJ; Wang HM; Yuann JM; Huang CY; Hou MH
J Inorg Biochem; 2009 Dec; 103(12):1626-33. PubMed ID: 19800127
[TBL] [Abstract][Full Text] [Related]
32. NMR investigation of mithramycin A binding to d(ATGCAT)2: a comparative study with chromomycin A3.
Banville DL; Keniry MA; Shafer RH
Biochemistry; 1990 Oct; 29(39):9294-304. PubMed ID: 2148686
[TBL] [Abstract][Full Text] [Related]
33. Influence of Mg2+ and Cd2+ on the interaction between sparfloxacin and calf thymus DNA.
Yuan XY; Guo DS; Wang LL
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Apr; 69(4):1130-5. PubMed ID: 17660000
[TBL] [Abstract][Full Text] [Related]
34. Studies of sequence-specific DNA binding, DNA cleavage, and topoisomerase I inhibition by the dimeric chromomycin A3 complexed with Fe(II).
Hou MH; Lu WJ; Lin HY; Yuann JM
Biochemistry; 2008 May; 47(20):5493-502. PubMed ID: 18426223
[TBL] [Abstract][Full Text] [Related]
35. Role of mg2+ in chromomycin a3 - DNA interaction: a molecular modeling study.
Chakrabarti S; Dasgupta D; Bhattacharyya D
J Biol Phys; 2000 Sep; 26(3):203-18. PubMed ID: 23345722
[TBL] [Abstract][Full Text] [Related]
36. Binding and thermodynamics of REV peptide-ctDNA interaction.
Upadhyay SK
Biopolymers; 2017 Mar; 108(2):. PubMed ID: 27353011
[TBL] [Abstract][Full Text] [Related]
37. Multivariate spectrochemical analysis of interactions of three common Isatin derivatives to calf thymus DNA in vitro.
Shahbazy M; Pakravan P; Kompany-Zareh M
J Biomol Struct Dyn; 2017 Sep; 35(12):2539-2556. PubMed ID: 27593978
[TBL] [Abstract][Full Text] [Related]
38. Chromomycin, mithramycin, and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Footprinting with (methidiumpropyl-EDTA)iron(II).
Van Dyke MW; Dervan PB
Biochemistry; 1983 May; 22(10):2373-7. PubMed ID: 6222762
[TBL] [Abstract][Full Text] [Related]
39. Interaction of a copper (II) complex containing an artificial sweetener (aspartame) with calf thymus DNA.
Shahabadi N; Khodaei MM; Kashanian S; Kheirdoosh F
Spectrochim Acta A Mol Biomol Spectrosc; 2014; 120():1-6. PubMed ID: 24177861
[TBL] [Abstract][Full Text] [Related]
40. Binding affinities of Schiff base Fe(II) complex with BSA and calf-thymus DNA: Spectroscopic investigations and molecular docking analysis.
Rudra S; Dasmandal S; Patra C; Kundu A; Mahapatra A
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Sep; 166():84-94. PubMed ID: 27214273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
